Conceptual Framework to Support Clinical Trial Optimization and End-to-End Enrollment Workflow

In this work, we present a conceptual framework to support clinical trial optimization and enrollment workflows and review the current state, limitations, and future trends in this space. This framework includes knowledge representation of clinical trials, clinical trial optimization, clinical trial design, enrollment workflows for prospective clinical trial matching, waitlist management, and, finally, evaluation strategies for assessing improvement.

[1]  Evangelos Kontopantelis,et al.  Using electronic health records to quantify and stratify the severity of type 2 diabetes in primary care in England: rationale and cohort study design , 2018, BMJ Open.

[2]  Licong Cui,et al.  Trial Prospector: Matching Patients with Cancer Research Studies Using an Automated and Scalable Approach , 2014, Cancer informatics.

[3]  Celette Sugg Skinner,et al.  Social Disadvantage, Healthcare Utilization, and Colorectal Cancer Screening: Leveraging Longitudinal Patient Address and Health Records Data , 2018, Cancer Epidemiology, Biomarkers & Prevention.

[4]  Christine M. Micheel,et al.  Abstract LB-104: Clinical actionability and clinical trial matching for GENIE patient genotypes using My Cancer Genome, Personalized Cancer Therapy, and OncoKB , 2017 .

[5]  Hong Sun,et al.  Semantic processing of EHR data for clinical research , 2015, J. Biomed. Informatics.

[6]  AACR Project GENIE: Powering Precision Medicine through an International Consortium. , 2017, Cancer discovery.

[7]  Stephen T. C. Wong,et al.  Correlating mammographic and pathologic findings in clinical decision support using natural language processing and data mining methods , 2017, Cancer.

[8]  Timothy F Platts-Mills,et al.  Discrepancies between ClinicalTrials.gov recruitment status and actual trial status: a cross-sectional analysis , 2017, BMJ Open.

[9]  Edward S. Kim,et al.  Broadening Eligibility Criteria to Make Clinical Trials More Representative: American Society of Clinical Oncology and Friends of Cancer Research Joint Research Statement. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  Arika E. Wieneke,et al.  Validation of natural language processing to extract breast cancer pathology procedures and results , 2015, Journal of pathology informatics.

[11]  Ronan A Lyons,et al.  Identifying patients with asthma-chronic obstructive pulmonary disease overlap syndrome using latent class analysis of electronic health record data: a study protocol , 2018, npj Primary Care Respiratory Medicine.

[12]  J. DeShazo,et al.  Effort required in eligibility screening for clinical trials. , 2012, Journal of oncology practice.

[13]  Anuradha Lakshminarayana,et al.  The clinical trial landscape in oncology and connectivity of somatic mutational profiles to targeted therapies , 2016, Human Genomics.

[14]  Paolo Boffetta,et al.  Adult cancer clinical trials that fail to complete: an epidemic? , 2014, Journal of the National Cancer Institute.

[15]  加藤和人 Global Alliance for Genomics and Health(GA4GH):ゲノムデータと臨床データの責任ある共有に向けた新しいイニシアティブ , 2015 .

[16]  Scott R. Halgrim,et al.  Using natural language processing to improve efficiency of manual chart abstraction in research: the case of breast cancer recurrence. , 2014, American journal of epidemiology.

[17]  James Lindsay,et al.  MatchMiner: An open source computational platform for real-time matching of cancer patients to precision medicine clinical trials using genomic and clinical criteria , 2017, bioRxiv.

[18]  John D Seigne,et al.  Development of a Natural Language Processing Engine to Generate Bladder Cancer Pathology Data for Health Services Research. , 2017, Urology.